Table 2

Number of double-stained CTCs/250,000 PBMCs in early and metastatic breast cancer patientsa

Early breast cancer

Metastatic breast cancer


Patient

Vim+CK+

Vim-CK+

Twist+CK+

Twist-CK+

Patient

Vim+CK+

Vim-CK+

Twist+CK+

Twist-CK+


1

64

51

83

100

1

5

0

4

0

2

25

63

29

142

2

45

0

8

0

3

31

111

578

68

3

21

0

7

0

4

35

28

53

85

4

2

0

4

0

5

135

199

18

134

5

74

20

45

0

6

100

158

28

170

6

7

7

3

6

7

170

254

89

423

7

7

2

420

0

8

0

0

74

4

8

21

69

2

0

9

0

1

71

95

9

10

90

3

0

10

140

4

0

1

10

2

0

2

0

11

22

0

0

0

11

3

15

103

36

12

17

0

74

88

12

67

3

9

1

13

0

4

8

0

13

4

0

0

0

14

0

0

0

3

14

3

3

42

0

15

7

1

0

4

15

1

0

1

0

16

10

3

12

0

16

1

0

1

0

17

0

0

0

0

17

10

2

55

0

18

28

12

0

0

18

325

97

5

7

19

0

0

0

10

19

17

1

13

0

20

0

1

2

0

20

3

0

0

0

21

2

0

13

0

21

2

0

2

0

22

2

0

0

9

22

2

1

2

0

23

306

0

380

0

23

9

0

658

0

24

1

0

0

2

24

192

4

44

0

25

24

0

1

0

25

40

0

80

0


aCTCs = circulating tumour cells; PBMCs = peripheral blood mononuclear cells; Vim = vimentin; CK = cytokeratin.

Kallergi et al. Breast Cancer Research 2011 13:R59   doi:10.1186/bcr2896

Open Data